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To limit responses to extracellular self-nucleic acids, TLRs localize to intracellular compartments 24 and require proteolytic cleavage within their ectodomains for activation [7] [8] [9] [10] significantly reduced TLR9 signaling, whereas G283S had no effect (Fig. 3e) . The reduction in signaling 129 was specific to TLR9, as none of the human Unc93b1 variants reduced TLR7 signaling (Fig. S4) S282A is sufficient for the TLR9 signaling defect. TNFα production, measured by ELISA, from the indicated RAW macrophage lines after stimulation for 8h with CpG-B, CpG-A, or LPS (50ng/ml) (n=3, representative experiment of two independent repeats). (e) Quantitative RT-PCR analysis of Tnfa and Ifnb expression in the indicated RAW macrophage lines 8h after stimulation with CpG-A/DOTAP (1µM) or LPS (10ng/ml) (n=3, representative experiment of two independent repeats). (f) Unc93b1 S282A does not affect TLR9 trafficking to endosomes. Whole cell lysates (WCL) or lysates of phagosomes isolated from the indicated RAW macrophage lines were probed for levels of TLR9, Lamp1, Calnexin, and GAPDH by immunoblot; FL: full-length. All data are mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired Student's t-test (qRT-PCR) or two-way ANOVA followed by a Bonferroni posttest (ELISA). The data are representative of at least three independent experiments, unless otherwise noted. SKN and Unc93b1 S282A bind stronger to TLR9. Flag immunoprecipitation of Unc93b1 from RAW macrophage lines, expressing TLR9-HA and the indicated Unc93b1 alleles, followed by immunoblot of TLR9. Input levels of TLR9 in whole cell lysates (WCL) are also shown. Bar graph shows quantification of TLR9 bound to Unc93b1 from several experiments. (d) HA immunoprecipitation of TLR9 from phagosome preparations of RAW macrophage lines, expressing TLR9-HA and the indicated Unc93b1 alleles, followed by immunoblot for Unc93b1. Input levels of TLR9 and Unc93b1 in phagosomes and whole cell lysates (WCL) are also shown; FL: full-length. Representative of two independent experiments. All data are mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired Student's t-test. The data are representative of at least three independent experiments, unless otherwise noted. Data are normalized to Unc93b1-independent hIL-1b responses and expressed as luciferase fold change over unstimulated controls (n=4, representative of two independent experiments). One-way ANOVA results: F(5/12)=300.0, p<0.0001 (e) NF-κB luciferase assay in HEK293T cells expressing TLR9 and the indicated human Unc93b1 variants and stimulated with CpG-B (250nM) for 16hrs. Data is normalized to Renilla expression and expressed as relative luciferase units (RLUs) (n=7, pooled from two independent experiments). One-way ANOVA results: F(3/12)=9.45, p=0.0017 All data are mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 by one-way ANOVA followed by a Tukey's posttest. Fig. 4 . TLR9, but not TLR7, must release from Unc93b1 for signaling. (a) Sub-cellular fractionation of TLR9-HA, Unc93b1-FLAG expressing RAW macrophages was performed by density-gradient centrifugation. The distributions of Calnexin, Lamp1, Unc93b1, and TLR9 were measured by immunoblot. The pooled fractions, enriched for endosomes or ER, used for subsequent coimmunoprecipitation experiments are highlighted. (b) The TLR9-Unc93b1 association is reduced in endosomes compared to the ER. HA immunoprecipitation of TLR9 from pooled ER or endosome fractions (as shown in (a)) from RAW macrophage lines expressing TLR9-HA and the indicated Unc93b1 alleles. Immunoprecipitated TLR9-HA levels were normalized across fractions and probed for levels of Unc93b1. Bar graph shows the quantification of Unc93b1 bound to TLR9 across fractions. (c) Unc93b1 is absent from the active TLR9 signaling complex. Immunoprecipitation of MyD88 from RAW macrophage lines expressing TLR9-HA and the indicated Unc93b1 alleles and stimulated for 1h with CpG-B (1µM), followed by immunoblot for TLR9 and Unc93b1. Shown are also input levels of TLR9 and Unc93b1 in whole cell lysates (WCL). Representative of two independent experiments. (d) Release model of TLR9. (e) Unc93b1-tethered TLR9 is unable to signal. HA immunoprecipitation of TLR9 under non-reducing conditions from RAW macrophage lines expressing the indicated TLR9 and Unc93b1 cysteine mutants. Eluted proteins were either treated with the reducing agent dithiothreitol or left untreated and probed for Unc93b1. The non-reducing condition visualizes disulfide-bond formation between Unc93b1 and TLR9, which disappears after treatment with dithiothreitol (reducing condition). Bar graph shows an NF-κB luciferase assay in HEK293T cells expressing the indicated cysteine mutant combinations and stimulated with CpG-B (1µM) for 16hrs. Data are normalized to Renilla expression and expressed as relative luciferase units (RLUs) (n=4; representative of three independent experiments). (f) TLR7 does not release from Unc93b1 in endosomes. HA immunoprecipitation of TLR9 and TLR7 from pooled ER or endosome fractions of RAW macrophage lines expressing WT Unc93b1. Immunoprecipitated TLR-HA levels were normalized across fractions and probed for levels of Unc93b1. Bar graph shows the quantification of Unc93b1 bound to TLR9 or TLR7 between ER and endosome fractions; FL: full-length. All data are mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 by paired Student's t-test (b, f) or unpaired Student's t-test (e). The data are representative of at least three independent experiments, unless otherwise noted.
Supplementary Materials for
An essential checkpoint for TLR9 signaling is release from Unc93b1 in endosomes
Olivia Majer, Brian J Woo, Bo Liu, Erik Van Dis, and Gregory M Barton Correspondence to: barton@berkeley.edu
This PDF file includes:
Figs. S1 to S5 , bind stronger to TLR9. Flag immunoprecipitation of Unc93b1 from RAW macrophage lines, expressing the indicated Unc93b1 alleles, followed by immunoblot of TLR9. Input levels of TLR9 in whole cell lysates (WCL) are also shown; FL: full-length. The data are representative of at least two independent experiments, unless otherwise noted. Fig. S4 . Human Unc93b1 variants do not reduce TLR7 signaling. NFκB activation was measured by luciferase assay in HEK293T cells transiently transfected with TLR7 and the indicated human Unc93b1 variants and stimulated with R848 (250ng/ml) for 16hrs. Data are normalized to Renilla expression and expressed as relative luciferase units (RLUs) (n=3, representative of three independent experiments). Expression levels of human Unc93b1 variants are shown below. All data are mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001 by oneway ANOVA followed by a Tukey's posttest. On-way ANOVA results: F(3/8)=29.70, p=0.0001 
